From the impact of stringent regulations to the shift toward new indications and rising market segments, SmartTRAK explores some of the trends to watch for in 2022 and beyond.
Orthopedic regenerative medicine therapy as an emerging area of science holds great promise for treating and promoting faster healing in a variety of injuries. There is also a belief among some scientists and industry stakeholders that it may hold the key to halting or reversing degenerative chronic conditions through self-healing. In a previous article, SmartTRAK had highlighted several challenges that Regenerative Medicine therapies would need to overcome to become a fully viable business and recognized treatment solution for patients. In 2021, businesses, societies and health care systems across the world continued to experience disruptions from the COVID-19 pandemic and its subsequent waves of variants. Furthermore, much greater scrutiny and tougher regulations for some of the injectable regenerative medicine therapies were put into place. The start of 2022 is also not quite as “rosy” as most had hoped for ...
COVID-19 has thrown another curveball with the onset of the OMICRON variant. Once again, healthcare facilities had to postpone elective procedures, but now, staffing has become a major issue. Additionally, patients are learning to manage their condition on their own and/or are being diagnosed with COVID. Inflation in the US accelerated to 7.5% in January, the highest since February of 1982 and well above market forecasts of 7.3%, as soaring energy costs, labor shortages, and supply disruptions weigh. Inflation has accelerated for medical care services to 2.7% vs 2.5%. Is this the “perfect storm” no one wanted or is it just a heavy shower passing by? SmartTRAK looks at some main trends in the injectable regenerative medicine therapies market in the US ...
To download and read the complete article entitled "Injectable Regenerative Medicine Therapies: Trends To Watch in 2022 and Beyond" by Freddy Buntoum, SmartTRAK Senior Analyst, Orthobiologics and Regenerative Medicine, please click the button below.
SmartTRAK is the leading source of competitive intelligence used by the top ten global orthopedic & wound care companies. If you would like a demo of what SmartTRAK has to offer and see how we can help increase proficiency, improve productivity and reduce costs for your company, just click the button below.
